Half-thickness Tragal Cartilage Graft vs Temporalis Fascia Graft Tympanoplasty Type I (PTA)

January 24, 2019 updated by: Fazal Wahid, Lady Reading Hospital, Pakistan

Comparison of Half-thickness Tragal Cartilage Graft to Temporalis Fascia Graft

The rationale of this study is to find out the surgical outcome and success rates of tragal cartilage and temporalis fascia, subsequently to develop guide line in light of the results of this study for our department as our institute is going to follow one patient in one bed policy in future. The purpose of this study is to compare the graft success rate of cartilage versus temporalis fascia in tympanoplasty type I in our institute, as no such study has been conducted in our province before.

Study Overview

Detailed Description

Tympanic membrane is forming lateral wall of the middle ear cleft which separates middle ear from the external auditory canal. It is made of three layers except in the upper part (Pars Flaccida). The outer layer of TM (Tympanic Membrane) is made of epithelium; middle layer is fibrous tissue, while inner layer is mucosal lining. The thickness of TM measures 0.1 mm, having diameter of 7-10 mm, weighing approximately 14 mg. The function of TM is to assist in hearing and protection of middle ear from infection. Perforation in tympanic membrane is the loss in continuity of TM layers. The causes of TM perforation may be trauma like blast, accident and firearm or infection of the middle ear like acute or chronic suppurative otitis media. It can also be iatrogenic as in case of placement of grommet for glue ear. The purpose of Tympanoplasty is to reconstruct TM perforation and restores sound conducting mechanism. In 1955, Zoellner and Wullstein used different types of graft materials for tympanoplasty. Later Heermann introduced cartilage palisade graft labeled as Simmering Technique. Similarly Goodhill also introduced first cartilage perichondrium composite graft material. Different graft materials can be used to close the TM defect. Some of these materials are temporalis fascia, tragal cartilage, perichondrium and fat. Temporalis fascia and tragal perichondrium had more anatomic proximity, compliance and translucency. The mode of action of these biological graft materials is that it provides support for the membrane remnant to proliferate and heal the defect. The temporalis fascia is thin, translucent and available in sufficient amount; but due to its close resemblance with tympanomeatal flap in color it may be displaced unintentionally during handling. However the reported success rate of temporalis fascia graft in literature varies from 93 to 97%.

On the other hand cartilage is middle ear friendly and survives for comparatively longer time due to the fact that its nourishment is based on diffusion process. Due to rigid nature of cartilage it prevents medialization of the graft to promontory in case of severe eustachian tube dysfunction. Cartilage graft is used in cases of chronically malfunction eustachian tube, adhesive otitis media, recurrent perforation and large TM perforation. But its demerits are its thick nature which hinders sound conduction and it is limited availability. The success rate of the cartilage graft tympanoplasty varies in the literature from 43 - 100%.

Chronic suppurative otitis media is an endemic health problem in our society. The reasons could be probably low literacy level, communities situated far flung from health facilities, lack of specialist service to the public in outreach area and inappropriate treatment of the middle ear infections. Sufficient number of patient suffering from inactive mucosal chronic otitis media with decreased hearing are presenting to otolaryngology unit. Tympanoplasty is the surgery of choice for chronic otitis media inactive mucosal type.

Hypothesis is that cartilage graft tympanoplasty is more successful than temporalis fascia tympanoplasty.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Khyberpakhtunkhwa
      • Peshawar, Khyberpakhtunkhwa, Pakistan, 25000
        • Fazali Wahid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 60 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients of both genders in the age range 16 - 60 years.
  • Inactive mucosal COM remained dry for at least one month.
  • Conductive hearing loss with minimum air-bone gap (ABG) of 10 Decibel (dB).
  • Middle ear is free of disease.

Exclusion Criteria:

  • Attic and / or posterior retraction pocket with cholesteatoma.
  • Ossicular chain dysfunction and associated otogenic complication.
  • Active mucosal COM.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: tympanoplasty with tragal cartilage
Tympanoplasty was performed using tragal cartilage graft
tympanoplasty type I is performed using tragal cartilage in arm 1
Active Comparator: tympanoplasty with temporalis fascia
Tympanoplasty was performed using temporalis fascia graft
tympanoplasty type I is performed using temporalis fascia in arm 2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Graft take up
Time Frame: 06 months of follow up
the graft take rate is determined in both the groups
06 months of follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective change in hearing level
Time Frame: 03 months of follow up
Change in hearing level is objectively assessed by performing pure tone audiometry and that is recorded in decibels on audiogram
03 months of follow up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hearing satisfaction: whispering test
Time Frame: 05 months of follow up
Individual hearing satisfaction will be assessed subjectively, by whispering test in which whispering sound is offered to the individual and improvement in hearing level is recorded on proforma
05 months of follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Zahid Nazar, Lady Reading Hospital, Peshawar, Pakistan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

December 31, 2017

Study Completion (Actual)

December 31, 2017

Study Registration Dates

First Submitted

December 28, 2018

First Submitted That Met QC Criteria

January 24, 2019

First Posted (Actual)

January 25, 2019

Study Record Updates

Last Update Posted (Actual)

January 25, 2019

Last Update Submitted That Met QC Criteria

January 24, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

This data can be share with other researcher through indexed journal

IPD Sharing Time Frame

UPTO 5 YEARS

IPD Sharing Access Criteria

in 6 months and for 5 years

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)
  • Analytic Code

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hearing Loss,Conductive

Clinical Trials on Tympanoplasty using tragal cartilage graft

3
Subscribe